How to Value a Cannabis Cultivation Business in 2026
Cannabis cultivation is the single hardest SMB vertical I value. The reasons stack on top of each other: federal illegality creates financing and banking chaos, 280E tax treatment destroys real cash flow, wholesale flower prices have crashed 40-70% in most mature markets, license values swing wildly by state, and the quality of earnings reporting is — to be generous — inconsistent. A grower with $15M in revenue and a shiny new indoor facility can be worth $30M or $3M depending on which state it operates in and whether the license is scarce.
This is the only industry where I tell sellers to start the valuation conversation with two numbers: the operating business value and the license value. They're not the same, and in many cases the license is worth more than the business that uses it. Here's how cannabis cultivation valuation actually works in 2026.
The Range: 2-5x EBITDA, Plus License Premium
State-legal cannabis cultivators generally trade in a 2-5x EBITDArange for the operating business, with a separate premium attached to the license itself in limited-license states. That premium can run from zero (California, Oregon, Colorado — saturated markets) to $5M-$25M per license(New York, New Jersey, Massachusetts early rounds, Florida medical).
Why the multiples are so low compared to other agriculture: 280E means cultivators can't deduct most operating expenses for federal tax purposes, which makes GAAP EBITDA almost meaningless. Buyers have to build to an after-tax cash flow number that's sometimes 40% lower than reported EBITDA. Layer on wholesale price compression, capital intensity, and regulatory risk, and you get multiples that look shockingly low to operators who thought cannabis was going to print money.
The buyer pool is smaller than most industries because federally-regulated capital (banks, most PE, all public equity) can't participate directly. Buyers are MSOs (multi-state operators), in-state consolidators, family offices with cannabis mandates, and occasionally foreign capital. Each has different sensitivities, and matching your business to the right buyer type matters more than squeezing another 0.2x out of any individual deal.
License Value: The State-by-State Reality
License scarcity is the single biggest driver of cultivation value, and it varies enormously by state. Here's roughly how the map looks in 2026:
- California, Oregon, Washington, Colorado: Unlimited or near-unlimited cultivation licenses. License value is effectively zero. Valuation is pure operating multiple, and most cultivators are distressed.
- Michigan, Arizona, Nevada, Illinois: Capped but generous license allocations. Mild license premium of $500K-$2M depending on canopy and tier.
- Massachusetts, New Jersey, Connecticut, New York: Tightly limited and high-demand markets. License premiums of $5M-$15M for tier-1 cultivation licenses.
- Florida, Georgia, Virginia: Vertically integrated medical programs with extreme license scarcity. A single license can carry $20M-$40M in standalone value.
What this means in practice: if you're selling a cultivator in Florida, the buyer isn't buying your grow operation — they're buying your license and the grow comes along for the ride. If you're selling in California, the license is free and the buyer wants to know your cost per pound, your genetics library, and your wholesale relationships.
Cost Per Pound: The Operating Benchmark
Strip away license value and cannabis cultivation is just agriculture. The one metric that determines whether you have a sustainable business is fully-loaded cost per pound of trimmed flower. The benchmarks I see in 2026:
- Outdoor: $150-$300 per pound. Profitable even at today's depressed wholesale ($400-$700).
- Greenhouse/mixed-light: $350-$600 per pound. Profitable in most markets but margins are thin.
- Indoor: $500-$900 per pound. Only profitable if you're producing top-shelf flower commanding $1,200+ wholesale, or if you're in a high-price state.
Cultivators who can prove sub-$400 per pound all-in costs on indoor flower, with documented test results and consistent yields, trade at the top of the multiple range. Those running at $700+ per pound are on borrowed time regardless of what EBITDA currently looks like.
Named active acquirers in cultivation M&A have included Curaleaf, Green Thumb Industries, Cresco Labs, Trulieve, and Verano, though pace has slowed dramatically since the 2021-2022 peak. Most deals in the past 18 months have been strategic tuck-ins to support existing retail footprints, priced in the 2-4x EBITDA range plus license value.
280E and Why Your EBITDA Is a Lie
Section 280E of the federal tax code disallows ordinary business deductions for companies trafficking in Schedule I substances. Cannabis cultivators can only deduct cost of goods sold — not marketing, rent (except for the grow footprint itself), administrative salaries, or most overhead. The effective federal tax rate for a cannabis cultivator often runs 50-80% of real economic profit.
What this means for valuation: reported GAAP EBITDA overstates real cash flow. When I value a cultivator, I build a 280E-adjusted EBITDA number by calculating the actual federal tax bill and deducting it above the line. That's the number buyers underwrite. A cultivator reporting $4M in EBITDA might have $2.2M in 280E-adjusted cash flow, and the multiple applies to the $2.2M, not the $4M. If you're negotiating a deal based on the reported number, you're negotiating against yourself.
When normalizing EBITDA for a cannabis cultivator, I also work through excise tax pass-throughs, license-related legal and compliance spend, and any related-party leases — cannabis operators frequently own their grow real estate through a separate entity and need to normalize rent to market.
Regulatory Risk: The Invisible Discount
Every cannabis deal carries regulatory risk that buyers price aggressively. The biggest ones in 2026:
Interstate commerce. If federal descheduling or state compacts allow interstate shipping of cannabis, the value of in-state cultivation will collapse in high-cost states and rise in low-cost states (Oregon, southern Humboldt). Buyers model both scenarios and discount accordingly.
License renewal risk. Most state licenses require renewal every 1-3 years with compliance review. Any pending violations, tax delinquencies, or ownership-disclosure issues will either kill the deal or force a significant price cut.
Local control. City and county approvals can be revoked, restricted, or made more expensive. Cultivators in jurisdictions with unstable local politics get discounted.
Ownership-disclosure and disqualification rules. Some states have restrictions on who can hold cannabis licenses (criminal history, residency requirements, cross-ownership caps). Buyers will want comfort that the change of control can actually be approved.
What Moves the Multiple
Scarce license in a growth market. This is the single biggest value lever, and it's mostly out of the operator's control — you either have it or you don't.
Low cost per pound with documented consistency. Buyers reward operational discipline. Twelve months of batch data showing consistent yields, THC percentages, and test results is worth more than any brand story.
Vertical integration or wholesale relationships. A cultivator with locked-in wholesale buyers (dispensaries, processors, brands) at above-spot prices trades at a premium. A cultivator selling 100% to the spot market trades at a discount.
Clean compliance history. No recalls, no pesticide failures, no Metrc discrepancies, no tax delinquencies. A clean record is worth 0.5-1x on the multiple because it signals the buyer isn't inheriting problems.
Real estate ownership. Owning your cultivation real estate gives the buyer flexibility and often creates a separate sale-leaseback value stream that can be monetized independently.
The Bottom Line
Cannabis cultivation valuation is bifurcated: in scarce-license states, you're selling a license with a grow attached, and multiples are whatever the license is worth. In saturated markets, you're selling an agricultural business subject to 280E, and multiples are grim — 2-3.5x is realistic, not the 8-10x anyone was talking about in 2021. The best outcomes come from operators who built a business that's genuinely profitable on an after-tax basis, documented everything, and matched their exit to a buyer whose strategic need lines up with what they actually have.
Want to see what your business is worth?
Institutional-quality estimates backed by 25,000+ real M&A transactions.
Get Your Valuation EstimateRelated Reading
How to Value a Cannabis Dispensary
Retail cannabis valuation, license premiums, and vertical integration dynamics.
Business Valuation Multiples by Industry (2026 Data)
How cannabis multiples compare to other regulated and agricultural industries.
SDE vs EBITDA: Which One Values Your Business?
Why 280E makes cannabis EBITDA normalization uniquely complicated.